In addition, more recently, NTRK1, NTRK2, and NTRK3 kinase fusions have been detected in a very small proportion (<1%) of metastasizing non-spitzoid melanomas of adults, suggesting the opportunity of Trk inhibition therapy for this group of patients [31]. This evidence concerns the gene NTRK1 and melanoma.